Mia Wadelius - Concepedia

Author

Mia Wadelius

Also Known As

Almqvist C, Etienne-Grimaldi, Marie-Christine, Eva Feketeova, Jean‐Laurent Casanova, M WADELIUS, M Wadelius, M. WADELIUS, M. Wadelius, Mia Wadelius, Pirmohamed, Munir

168

Publications

12.4K

Citations

H-Index

Concepts

All Affiliations

Uppsala University Science for Life Laboratory Uppsala University Hospital University of Liverpool Karolinska Institutet

About

Mia Wadelius is an author at Uppsala University specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	27	4.9K
2	Public Health	12	13	3.5K
3	Social Sciences	2	2	64
4	Engineering	1	1	11
5	Health Sciences	1	1	146

Mia Wadelius

Publications

10.9K

Citations

H-Index

Page 1

	Year	Citations
A Randomized Trial of Genotype-Guided Dosing of Warfarin Munir Pirmohamed, Girvan Burnside, Niclas Eriksson, New England Journal of Medicine	2013	802
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update JA Johnson, KE Caudle, Li Gong, Clinical Pharmacology & Therapeutics ThrombosisCardiovascular DiseasePharmacologyGenetic EpidemiologyPediatric Patients	2017	664
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing J. A. Johnson, Li Gong, Michelle Whirl‐Carrillo, Clinical Pharmacology & Therapeutics ThrombosisTherapeutic Warfarin DoseTarget AnticoagulationWarfarin Dose VariabilityMedicine	2011	643
A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose Fumihiko Takeuchi, Ralph McGinnis, Stéphane Bourgeois, PLoS Genetics Genome-wide Association StudyThrombosisTherapeutic Warfarin DoseMedicineGenetics	2009	635
The largest prospective warfarin-treated cohort supports genetic forecasting Mia Wadelius, Leslie Y. Chen, Jonatan D. Lindh, Blood	2008	551
Common VKORC1 and GGCX polymorphisms associated with warfarin dose Mia Wadelius, L Y Chen, Kate Downes, The Pharmacogenomics Journal ThrombosisMedicineHematologyGenetic EpidemiologyPathology	2005	466
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update Laura B. Ramsey, Samuel G. Johnson, Kelly E. Caudle, Clinical Pharmacology & Therapeutics Slco1b1 GenotypeLipid DisorderCardiovascular DiseaseMedicineGenetic Epidemiology	2014	437
Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process Kelly E. Caudle, Teri E. Klein, James M. Hoffman, Current Drug Metabolism Genetic EpidemiologyPharmacotherapyGenetic MedicineGenotype-based Drug GuidelinesPharmacogenomics	2014	423
Association of warfarin dose with genes involved in its action and metabolism Mia Wadelius, Leslie Y. Chen, Niclas Eriksson, Human Genetics	2006	397
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups Nita A. Limdi, Mia Wadelius, Larisa H. Cavallari, Blood	2010	370

Page 1